Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,736.40
(
1.03%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
110.96
(
0.55%
)
Bitcoin
76,958.05
(
0.82%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: n4807g post# 24337

Tuesday, 02/21/2006 7:32:15 PM

Tuesday, February 21, 2006 7:32:15 PM

Post# of 257473
Re: INGN phase-1/2 results in lung cancer

http://biz.yahoo.com/prnews/060221/datu058.html?.v=26

>>
Following INGN 225 treatment and chemotherapy, 62% percent of evaluable patients demonstrated objective tumor responses.
<<

Why the heck doesn’t the PR say how many evaluable patients there were?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today